Vitamin D easily obtained with little or no sun exposure

Prof John Hawk - President of the World Congress on Cancers of the Skin 2014
Vitamin D easily obtained with little or no sun exposure ( Prof John Hawk - President of the World Congress on Cancers of the Skin 2014 )
11 Sep 2014

The importance of the World Congress on Cancers of the Skin

Prof John Hawk - President of the World Congress on Cancers of the Skin 2014
The importance of the World Congress on Cancers of the Skin ( Prof John Hawk - President of the World Congress on Cancers of the Skin 2014 )
11 Sep 2014

Risk of common skin cancer increased by as much as 90 per cent with sunbeds, study finds

Patrick Tierney - University of Dundee, Dundee, UK
Risk of common skin cancer increased by as much as 90 per cent with sunbeds, study finds ( Patrick Tierney - University of Dundee, Dundee, UK )
11 Sep 2014

Moles on the skin increase skin cancer risk

Dr Eugene Ong - University of Oxford, Oxford, UK
Moles on the skin increase skin cancer risk ( Dr Eugene Ong - University of Oxford, Oxford, UK )
11 Sep 2014

One in ten UK doctors admit to using sunbeds

Dr Jingyuan Xu and Dr Kim Varma
One in ten UK doctors admit to using sunbeds ( Dr Jingyuan Xu and Dr Kim Varma )
11 Sep 2014

ecancermedicalscience editor's choice for July and August 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for July and August 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
19 Aug 2014

Melanoma live: Making patient-focused therapy decisions

Prof Dirk Schadendorf; Dr Paul Nathan; Prof Georgina Long
Melanoma live: Making patient-focused therapy decisions ( Prof Dirk Schadendorf; Dr Paul Nathan; Prof Georgina Long )
1 Aug 2014

Complexity of intra- and inter-pathway loops in colon cancer and melanoma: Implications for targeted therapies

Prof René Bernards - Netherlands Cancer Institute, Amsterdam, The Netherlands
Complexity of intra- and inter-pathway loops in colon cancer and melanoma: Implications for targeted therapies ( Prof René Bernards - Netherlands Cancer Institute, Amsterdam, The Netherlands )
26 Jun 2014

Combining immunological and targeted agents in melanoma

Dr Axel Hoos - GlaxoSmithKline, Collegeville, USA
Combining immunological and targeted agents in melanoma ( Dr Axel Hoos - GlaxoSmithKline, Collegeville, USA )
26 Jun 2014

Advances in diagnostic devices in melanoma screening

Dr Alessandro Testori - European Institute of Oncology, Milan, Italy
Advances in diagnostic devices in melanoma screening ( Dr Alessandro Testori - European Institute of Oncology, Milan, Italy )
6 Jun 2014

PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against metastatic melanoma

Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, US
PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against metastatic melanoma ( Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, US )
2 Jun 2014

Ipilimumab and nivolumab achieves long-term survival in advanced melanoma

Prof Mario Sznol - Yale Cancer Center, New Haven, USA
Ipilimumab and nivolumab achieves long-term survival in advanced melanoma ( Prof Mario Sznol - Yale Cancer Center, New Haven, USA )
2 Jun 2014